common.study.topics.clinical

Ketorolac on Posterior Thoracolumbar Spinal Fusions

common.study.values.description

Ketorolac on Posterior Thoracolumbar Spinal Fusions

To determine is low-dose ketorolac use in the early post-operative period (within 48 hours) provides adequate analgesia without long term adverse effect on spinal fusion rates when compared to post-operative analgesia without the use of NSAIDs.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Saline

1 ml saline IV Q6H

Drug - Ketorolac

15 mg (15 mg/ml) IV Q6H

participant.views.study.view.additional

participant.views.study.view.scientific-title

The Effect of Ketorolac on Posterior Thoracolumbar Spinal Fusions: a Prospective Randomized Controlled Trial

common.study.values.clinical-trial-id

NCT03278691

participant.views.study.view.id

Qe1Z3a